1. Czech Republic Diabetes Care Devices Market Outlook to 2018
- Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 93
Price: Single User License – US$2500
Czech Republic Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin
Delivery
Summary
GlobalData’s new report, “Czech Republic Diabetes Care Devices Market Outlook to 2018 -
Glucose Monitoring and Insulin Delivery” provides key market data on the Czech Republic
Diabetes Care Devices market. The report provides value (USD million), volume (units) and
average price (USD) data for each segment and sub-segment within two market categories –
Glucose Monitoring and Insulin Delivery. The report also provides company shares and
distribution shares data for each of the aforementioned market categories. The report is
supplemented with global corporate-level profiles of the key market participants with information
on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Czech Republic Diabetes
Care Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi , LifeScan, Inc., Eli Lilly and
Company , Novo Nordisk A/S , Bayer HealthCare AG and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Czech Republic Diabetes
Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197502-czech-republic-diabetes-care-devices-market-outlook-to-2018-
glucose-monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Czech Republic 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, 2004-2018 10
3.3 Diabetes Care Devices Market, Czech Republic, Revenue Mix ($m), 2011 11
3.4 Diabetes Care Devices Market, Czech Republic, Category Contribution (%), 2011 12
3.5 Diabetes Care Devices, Czech Republic, Company Share (2010-2011) 19
4 Glucose Monitoring In Czech Republic 21
4.1 Glucose Monitoring, Market Segmentation 21
4.2 Glucose Monitoring Market, Czech Republic, Revenue Mix ($m), 2011 22
4.3 Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2011 23
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 24
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 28
4.5 Glucose Monitoring Overall Volume (2004-2018) 32
4.5.1 Blood Glucose Meters, Volume (2004-2018) 36
4.6 Glucose Monitoring Average Price (2004-2018) 40
4.7 Glucose Monitoring Distribution Share (2010-2011) 41
4.8 Glucose Monitoring, Czech Republic, Company Share (2010-2011) 42
5 Insulin Delivery In Czech Republic 44
5.1 Insulin Delivery, Market Segmentation 44

3. 5.2 Insulin Delivery Market, Czech Republic, Revenue Mix ($m), 2011 45
5.3 Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2011 46
5.4 Insulin Delivery Overall Revenue, (2004-2018) 47
5.4.1 Insulin Pens, Revenue (2004-2018) 51
5.4.2 Insulin Pumps, Revenue (2004-2018) 55
5.5 Insulin Delivery Overall Volume (2004-2018) 57
5.5.1 Insulin Pens, Volume (2004-2018) 61
5.5.2 Insulin Pumps, Volume (2004-2018) 65
5.6 Insulin Delivery Average Price (2004-2018) 67
5.7 Insulin Delivery Distribution Share (2010-2011) 68
5.8 Insulin Delivery, Czech Republic, Company Share (2010-2011) 69
6 Overview of Key Companies in Czech Republic Diabetes Care Devices Market 71
6.1 F. Hoffmann-La Roche Ltd. 71
6.1.1 Company Overview 71
6.1.2 Share in the Czech Republic Diabetes Care Devices Market 71
6.2 Sanofi 72
6.2.1 Company Overview 72
6.2.2 Share in the Czech Republic Diabetes Care Devices Market 72
6.3 LifeScan, Inc. 73
6.3.1 Company Overview 73
6.3.2 Share in the Czech Republic Diabetes Care Devices Market 73
6.4 Eli Lilly and Company 74
6.4.1 Company Overview 74
6.4.2 Share in the Czech Republic Diabetes Care Devices Market 74
6.5 Novo Nordisk A/S 75
6.5.1 Company Overview 75
6.5.2 Share in the Czech Republic Diabetes Care Devices Market 75
6.6 Bayer HealthCare AG 76
6.6.1 Company Overview 76
6.6.2 Share in the Czech Republic Diabetes Care Devices Market 76
6.7 Abbott Laboratories 77
6.7.1 Company Overview 77
6.8 Medtronic, Inc. 77
6.8.1 Company Overview 77
6.9 Becton, Dickinson and Company 78
6.9.1 Company Overview 78
6.10 Ypsomed Holding AG 78
6.10.1 Company Overview 78
6.11 Terumo Corporation 79
6.11.1 Company Overview 79
6.12 Animas Corporation 79
6.12.1 Company Overview 79

4. 6.13 Nipro Corporation 79
6.13.1 Company Overview 79
7 Diabetes Care Devices Market Pipeline Products 80
8 Financial Deals Landscape 84
8.1 Partnerships 84
8.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 84
8.1.2 Insulet Amends Licensing Agreement With Abbott Diabetes 85
9 Appendix 86
9.1 Definitions of Markets Covered in the Report 87
9.1.1 Diabetes Care Devices 87
9.2 Research Methodology 90
9.3 Secondary Research 90
9.4 Primary Research 91
9.5 Models 91
9.6 Forecasts 92
9.7 Expert Panels 92
9.8 GlobalData Consulting 92
9.9 Currency Conversion 93
9.10 Contact Us 93
9.11 Disclaimer 93
1.1 List of Tables
Table 1: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, 2004-
2018 10
Table 2: Diabetes Care Devices Market, Czech Republic, Category Contribution (%), 2011 12
Table 3: Diabetes Care Devices, Czech Republic, Cross-Segment Analysis, 2004-2018 14
Table 4: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, Historic,
2004-2011 16
Table 5: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant,
Forecast, 2011-2018 18
Table 6: Diabetes Care Devices, Czech Republic, Company Share by Revenue ($m), USD
Constant, 2010-2011 20
Table 7: Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2011 23
Table 8: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 25
Table 9: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 27
Table 10: Blood Glucose Meters, Czech Republic, Revenue ($m*) USD Constant, by Sub-
Segment, Historic, 2004-2011 29
Table 11: Blood Glucose Meters, Czech Republic, Revenue ($m*) USD Constant, by Sub-
Segment, Forecast, 2011-2018 31
Table 12: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011

5. 33
Table 13: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Forecast, 2011-2018
35
Table 14: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Historic,
2004-2011 37
Table 15: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Forecast,
2011-2018 39
Table 16: Glucose Monitoring, Czech Republic, Average Price ($), Historic, 2004-2011 40
Table 17: Glucose Monitoring, Czech Republic, Average Price ($), Forecast, 2011-2018 40
Table 18: Glucose Monitoring, Czech Republic, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 41
Table 19: Glucose Monitoring, Czech Republic, Company Share by Revenue ($m), USD Constant,
2010-2011 43
Table 20: Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2011 46
Table 21: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 48
Table 22: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 50
Table 23: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 52
Table 24: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 54
Table 25: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue ($m) USD
Constant, Historic, 2004-2011 55
Table 26: Insulin Pumps, Czech Republic, Revenue ($m) USD Constant, Forecast, 2011-2018 56
Table 27: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011 58
Table 28: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Forecast, 2011-2018 60
Table 29: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Historic, 2004-2011 62
Table 30: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Forecast, 2011-2018 64
Table 31: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units), Historic,
2004-2011 65
Table 32: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units) by Sub-
Segment, Forecast, 2011-2018 66
Table 33: Insulin Delivery, Czech Republic, Average Price ($), Historic, 2004-2011 67
Table 34: Insulin Delivery, Czech Republic, Average Price ($), Forecast, 2011-2018 67
Table 35: Insulin Delivery, Czech Republic, Distribution Share by Revenue ($m), USD Constant,
2010-2011 68
Table 36: Insulin Delivery, Czech Republic, Company Share by Revenue ($m), USD Constant,
2010-2011 70
Table 37: Diabetes Care DevicesMarket Pipeline Products 80
Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 84
Table 39: Insulet Amends Licensing Agreement With Abbott Diabetes 85

6. 1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 9
Figure 2: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, 2004-
2018 10
Figure 3: Diabetes Care Devices Market, Czech Republic, Revenue Mix ($m), 2011 11
Figure 4: Diabetes Care Devices Market, Czech Republic, Category Contribution (%), 2011 12
Figure 5: Diabetes Care Devices, Czech Republic, Cross-Segment Analysis, 2004-2018 13
Figure 6: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, Historic,
2004-2011 15
Figure 7: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant,
Forecast, 2011-2018 17
Figure 8: Diabetes Care Devices, Czech Republic, Company Share (%), 2011 19
Figure 9: Glucose Monitoring, Market Segmentation 21
Figure 10: Glucose Monitoring Market, Czech Republic, Revenue Mix ($m), 2011 22
Figure 11: Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2011 23
Figure 12: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 24
Figure 13: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 26
Figure 14: Blood Glucose Meters, Czech Republic, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 28
Figure 15: Blood Glucose Meters, Czech Republic, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 30
Figure 16: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011
32
Figure 17: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Forecast, 2011-2018
34
Figure 18: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Historic,
2004-2011 36
Figure 19: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Forecast,
2011-2018 38
Figure 20: Glucose Monitoring, Czech Republic, Company Share (%), 2011 42
Figure 21: Insulin Delivery, Market Segmentation 44
Figure 22: Insulin Delivery Market, Czech Republic, Revenue Mix ($m), 2011 45
Figure 23: Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2011 46
Figure 24: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 47
Figure 25: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 49
Figure 26: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 51

7. Figure 27: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 53
Figure 28: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue ($m) USD
Constant, Historic, 2004-2011 55
Figure 29: Insulin Pumps, Czech Republic, Revenue ($m) USD Constant, Forecast, 2011-2018 56
Figure 30: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011 57
Figure 31: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Forecast, 2011-2018 59
Figure 32: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Historic, 2004-2011 61
Figure 33: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Forecast, 2011-2018
63
Figure 34: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units), Historic,
2004-2011 65
Figure 35: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units), Forecast,
2011-2018 66
Figure 36: Insulin Delivery, Czech Republic, Company Share (%), 2011 69
Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),Czech Republic Diabetes Care
Devices Market, 2011 71
Figure 38: Sanofi, Company Share (%),Czech Republic Diabetes Care Devices Market, 2011 72
Figure 39: LifeScan, Inc., Company Share (%),Czech Republic Diabetes Care Devices Market,
2011 73
Figure 40: Eli Lilly and Company, Company Share (%),Czech Republic Diabetes Care Devices
Market, 2011 74
Figure 41: Eli Lilly and Company, Company Share (%),Czech Republic Diabetes Care Devices
Market, 2011 75
Figure 42: Bayer HealthCare AG, Company Share (%),Czech Republic Diabetes Care Devices
Market, 2011 76
Contact: sales@reportsandreports.com for more information.